Restarting Elective Orthopaedic Surgery During the COVID-19 Pandemic: Lessons Learned
Open Access
- 12 July 2021
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 13 (7) , e16343
Abstract
Introduction Coronavirus disease 2019 (COVID-19) resulted in postponing non-emergency elective surgeries beginning in April 2020. Our hospital successfully restarted elective orthopaedic surgery during the pandemic to help improve the quality of life of patients with chronic disabilities. This study describes the development of local protocols and pathways to allow for a safe restart of elective orthopaedic surgery in a COVID-19-free ‘green’ site. It includes the morbidity and mortality outcomes of those patients who underwent non-emergency orthopaedic operations during this time. Methods This is a prospective cohort study over an eight-week period evaluating 104 patients undergoing non-emergency orthopaedic procedures through a COVID-19-free surgical pathway. The primary outcome measure was 14-day postoperative mortality. The main secondary outcome measures were the development of a COVID-19 infection in the hospital and 14 days postoperatively as well as the need for intensive care unit admissions. Results No patients developed a COVID-19 infection. There were no intensive care unit admissions or postoperative deaths during our study time frame. There was no statistical difference seen for age (< 70 or > 70), gender, body mass index, or American Society of Anesthesiologists (ASA) grades in the development of postoperative complications. Conclusions This study describes a roadmap to setting up a protocolised elective operating service for orthopaedic surgery. It has shown that standardised protocols in a COVID-19-free ‘green’ site, preoperative COVID-19 testing, and adherence to national guidelines on self-isolation can help prevent developing COVID-19 infection postoperatively and reduce the risk of postoperative mortality.Keywords
This publication has 12 references indexed in Scilit:
- The theoretical mortality risk of an asymptomatic patient with a negative SARS-CoV-2 test developing COVID-19 following elective orthopaedic surgeryThe Bone & Joint Journal, 2020
- The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fracturesThe Bone & Joint Journal, 2020
- Safety evaluation of a strategy to restart elective orthopaedic surgery during the de-escalation phase of the COVID-19 pandemicBone & Joint Open, 2020
- Orthopaedic surgery in a time of COVID-19Bone & Joint Open, 2020
- Interpreting a covid-19 test resultBMJ, 2020
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and ApplicationAnnals of Internal Medicine, 2020
- Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infectioneClinicalMedicine, 2020
- Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012Heart, 2013
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987